Increased turnover of dopamine in caudate nucleus of detoxified alcoholic patients by Kumakura, Yoshitaka et al.
Increased Turnover of Dopamine in Caudate Nucleus of
Detoxified Alcoholic Patients
Yoshitaka Kumakura1,2,3*, Albert Gjedde1,2, Daniele Caprioli4, Thorsten Kienast5, Anne Beck5,
Michail Plotkin6, Florian Schlagenhauf5, Ingo Vernaleken7, Gerhard Gru¨nder7, Peter Bartenstein8,
Andreas Heinz5, Paul Cumming8
1Department of Neuroscience and Pharmacology, University of Copenhagen, Copenhagen, Denmark, 2Center for Functionally Integrative Neuroscience, Aarhus
University, Aarhus C, Denmark, 3Department of Nuclear Medicine, Tokyo University, Tokyo, Japan, 4Department of Experimental Psychology, Cambridge University,
Cambridge, United Kingdom, 5Department of Psychiatry, Charite´ - Universita¨tsmedizin Berlin, Berlin, Germany, 6Department of Nuclear Medicine, Charite -
Universita¨tsmedizin Berlin, Berlin, Germany, 7Department of Psychiatry, University of Aachen, Aachen, Germany, 8Department of Nuclear Medicine, Ludwig Maximilian
University of Munich, Munich, Germany
Abstract
A previous study of the DOPA decarboxylase substrate 6-[18F]fluoro-L-DOPA (FDOPA) with positron emission tomography
(PET) detected no difference of the net blood-brain transfer rate (Kin
app) between detoxified alcoholic patients and healthy
controls. Instead, the study revealed an inverse correlation between Kin
app in left ventral striatum and alcohol craving scores.
To resolve the influx and efflux phases of radiolabeled molecules, we independently estimated the unidirectional blood-
brain FDOPA clearance rate (K) and the washout rate of [18F]fluorodopamine and its deaminated metabolites (kloss), and we
also calculated the total distribution volume of decarboxylated metabolites and unmetabolized FDOPA as a steady-state
index of the dopamine storage capacity (Vd) in brain. The craving scores in the 12 alcoholics correlated positively with the
rate of loss (kloss) in the left ventral striatum. We conclude that craving is most pronounced in the individuals with relatively
rapid dopamine turnover in the left ventral striatum. The blood-brain clearance rate (K), corrected for subsequent loss of
radiolabeled molecules from brain, was completely normal throughout the brain of the alcoholics, in whom the volume of
distribution (Vd) was found to be significantly lower in the left caudate nucleus. The magnitude of Vd in the left caudate
head was reduced by 43% relative to the 16 controls, consistent with a 58% increase of kloss. We interpret the findings as
indicating that a trait for rapid dopamine turnover in the ventral striatum subserves craving and reward-dependence,
leading to an acquired state of increased dopamine turnover in the dorsal striatum of detoxified alcoholic patients.
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Introduction
In non-alcoholic drinkers, alcohol intake evokes acute release of
dopamine in ventral striatum, as revealed in vivo by reduction of
dopamine D2/3 receptor availability [1]. Repeated exposures to
alcohol subsequently alter the phasic and tonic dynamics of
dopamine release in rodent striatum [2–4] and therefore predict
similar changes of dopamine markers in patients with chronic
alcohol abuse. In detoxified alcoholic patients, the competition
between endogenous dopamine and exogenous tracer [11C]raclo-
pride, estimated by means of positron emission tomography (PET),
reveals attenuation of the dopamine release evoked by methyl-
phenidate [5] or amphetamine [6]. These observations raise the
question of changes in the dopamine synthesis capacity, which is
one of the most robust indicators of psychotic states [7]. In one
PET study of alcoholism, detoxified alcoholic patients had
significantly elevated influx of the DOPA decarboxylase substrate
6-[18F]fluoro-L-DOPA (FDOPA) to left putamen and right
caudate nucleus [8], while in a subsequent study, detoxified
alcoholic patients had no change of FDOPA uptake [9], although
a correlation was seen with alcohol craving.
The measure of the net blood-brain transfer rate of FDOPA
obtained in these studies of alcoholic patients (Kin
app; ml
g21 min21) reflects both formation of [18F]fluorodopamine and
the subsequent washout of diffusible acidic metabolites [10], which
are known to respond differentially to changes of trait or state
markers of dopaminergic neurotransmission [11–16], as shown
previously [17,18]. The analysis separating synthesis from loss in
the dopamine metabolic pathway yields the unidirectional
clearance rate of FDOPA to brain tissue by enzymatic actions
(K; ml g21 min21) and the fractional rate constant for elimination
of [18F]fluorodopamine and its metabolites (kloss; min
21). The ratio
between the enzymatic clearance of FDOPA (K) and the rate of
loss (kloss) constitutes a steady-state volume of distribution for the
decarboxylated and deaminated metabolites, which reflects the
total distribution volume in brain (Vd; ml g
21), an index of
dopamine storage capacity, as detailed in the earlier publications
[19–22].
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We predicted that the previous finding of an inverse correlation
between the net blood-brain transfer (Kin
app) and alcohol craving
scores [23] was derived from trait-dependent differences of the
catabolism of [18F]fluoro-dopamine formed in ventral striatum
and subsequent washout of the breakdown products [24]. Here,
we tested the hypotheses, first, that the individual rates of
[18F]fluorodopamine washout (kloss) in the left ventral striatum
would correlate with the severity of craving in the group of
alcoholics, as previously noted for the net blood-brain transfer
(Kin
app), and second, that the analysis would reveal increased kloss
throughout striatum of detoxified alcoholic patients, relative to an
age-matched control group.
Materials and Methods
Subject Recruitment
All subjects provided written informed consent for participation
in the studies which had been approved by the local Research and
Ethics Committees of both universities in Denmark and Germany
(De Videnskabsetiske Komite´er for Region Midtjylland, Ethik-
kommission der Landesa¨rztekammer Rheinland Pfalz). The
control group consisted of the 12 volunteers from the earlier
study [23], augmented with four additional subjects from other
studies [22,25,26], giving a total of 16 healthy right-handed male
subjects aged 32–55 years (mean 43.268.1 years). Twelve right-
handed detoxified male patients with alcoholism aged 32–57 years
(mean 42.567.5 years) were the patient cohort in the previously-
published FDOPA PET study [23]. The healthy control subjects
had no psychiatric axis I or II disorders, according to assessment
with the SCID [27,28]. All control subjects were non-smokers.
The patients met the ICD-10 and DSM-IV criteria for alcohol
dependence and had no other axis I psychiatric disorders and no
past history of drug dependence or current drug abuse, according
to assessment with random urine and breath tests in a supervised
inpatient treatment program for a mean of 36 days (SD 22) prior
to scanning [9].
The mean (6 SD) alcohol lifetime alcohol consumption of the
patients was 10386828 kg, and they smoked a mean (6 SD) of
17613 cigarettes per day, yielding a weak trend towards
correlation between individual alcohol and cigarette consumption
(r = 0.27; n.s.). The lifetime alcohol intake was measured with the
Lifetime Drinking History questionnaire [29]. The severity of
current alcohol craving was measured with the Alcohol Craving
Questionnaire (ACQ: [30]) on the morning before FDOPA PET
scanning. The ACQ is a widely and internationally used
instrument with good test-retest reliability (kappa = 0.85,
p,0.001; tested in 46 alcoholic subjects on two separate days)
and high internal consistency (Cronbach’s alpha = 0.96, p,0.001,
N = 243). Daily smoking habits reported by the patients and
control subjects were recorded, and treated as a nuisance
parameter in statistical analyses for the voxelwise group compar-
isons and correlations with ACQ scores.
PET Scanning and Plasma Sampling Procedure
Subjects fasted overnight, and received carbidopa (Merck
Sharpe and Dohme; 2 or 2.5 mg/kg, p.o.) one hour prior to the
PET scan in order to minimize the decarboxylation of FDOPA in
peripheral tissues [31]. Dynamic attenuation-corrected emission
images were acquired with ECAT EXACT 47 whole body PET
scanners (CTI/Siemens, Knoxville, TN), as described in detail in
the earlier report [23] during 120 minutes following intravenous
injection of FDOPA (200 MBq). Total radioactivity concentration
in serial samples of arterial blood was measured in well-counters
cross-calibrated to the tomographs. The fractions of untrans-
formed FDOPA and its major plasma metabolite 3-O-methyl-6-
[18F]fluoro-L-DOPA (OMFD) were determined in selected sam-
ples by reverse-phase high performance liquid chromatography
[31]. Continuous plasma input functions for FDOPA and OMFD
were calculated by fitting bi-exponential functions to the measured
fractions [32].
In the present study, dynamic PET sequences were realigned
and corrected frame-wise for head motion, and then summed and
registered to the Montreal Neurological Institute (MNI) stereotaxic
brain, as described previously [19,25]. In short, we created a tissue
image, which represented mean radioactivity distribution averaged
over the time period of 20–120 min, after preparatory frame-wise
head motion correction. The FDOPA tissue image then under-
went linear transformation to the MRI gray matter template
image of the MNI space, which was modified for voxel intensity
distribution to mimic FDOPA accumulation of striatum and
cerebral cortex. In the process of transformation to the MNI space,
the linear transformation algorithm was weighted more towards
striatum than cerebral cortex contour. This weighting also
minimizes the potential atrophy effect in striatum.
Sixty minute cerebellum TACs were first analyzed using a
constrained compartment model with dual arterial inputs for
OMFD and FDOPA [10,13]. The VOI template of cerebellum
had a sufficiently large volume of 48 cm3 to minimize partial
volume effects related to potential atrophy. The OMFD concen-
tration curve in brain calculated relative to the entire 120 min
OMFD input was then globally subtracted from the entire
dynamic emission sequence [21]. Briefly, we first estimated kinetic
parameters for OMFD, and then precisely identifid the OMFD
accumulation in cerebellum, using the basic K1-k2 neurokinetic
model. The OMFD curve was regenerated mathematically for
subtraction of OMFD contamination. This OMFD subtraction
method permits the two hour tomography, which is sufficient for
subsequent parameter estimation of the present study. Following
this mathematical subtraction of brain OMFD, FDOPA kinetics in
brain simplifies to an ‘‘inlet-outlet’’ model [17,19,20,33], com-
prising the intrinsic blood-brain clearance rate of FDOPA (K, ml
g21 min21), and the fractional rate constant for the process of
elimination of [18F]fluorodopamine together with its deaminated
metabolites from brain (kloss, min
21). The ratio (K/kloss) is analogous
to an effective distribution volume (EDV ml g21), as defined in
[15]. In the method used here, the steady-state total tracer
distribution volume in brain (Vd, ml g
21) equals the sum of the
FDOPA plasma volume (V0, ml g
21), the distribution volume of
unmetabolized FDOPA in brain (Vf, ml g
21), and the decarbox-
ylated metabolite pool, consisting of [18F]fluorodopamine and its
deaminated metabolites (K/kloss ml g
21; see [19], Fig. 2C). Robust
estimates of this triad of kinetic parameters are obtained through a
multi-linear solution of a set of first-order differential equations,
using the OMFD-subtracted brain TACs in the interval from 20 to
120 min [17,20].
To search for brain regions with perturbed [18F]fluorodopa-
mine kinetics, we calculated parametric Vd maps in the native PET
space using MATLAB (The Mathworks, Natick, MA). In the
common MNI stereotaxic space after anatomical standardization,
mean Vd maps were calculated for the two groups, and difference
maps were calculated by subtraction. Voxel-wise statistical analysis
was performed using the general linear model (GLM), in order to
search for cluster volumes and partial out the effects of smoking
rates. Group differences and voxel-wise regression of Vd with ACQ
scores for the 12 patients were calculated using the GLM
implemented in Glim Image, a program developed at the MNI.
Then, cluster VOIs were defined directly from the raw t-maps,
where the t-value threshold was set arbitrary to form a cluster
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(t.2.5–2.8), but as high as possible to avoid false positive voxels.
The cluster VOIs identified in the Vd voxelwise contrast and
regression analyses were applied to the OMFD-subtracted
dynamic 4D recordings for TAC extraction, and the individual
magnitudes of K, kloss and Vd were calculated separately from the
TACs. The kinetic estimates obtained from the cluster VOIs were
tested using the GLM analysis for the contrast between alcoholic
and control groups as well as the regression with ACQ scores,
treating individual smoking rates as a nuisance variable.
Results
On average, the group of detoxified alcoholics had reduced
[18F]fluorodopamine storage capacity, as revealed by both the
mean parametric Vd map (Figure 1A,B) and the subtraction map
(Figure 1C,D). The voxelwise comparison revealed a large cluster
(t .2.8) in the left medial caudate nucleus where the mean
magnitude of Vd was lower in the alcoholic group (Figure 1E).
Within this cluster, the mean magnitudes of K did not differ
significantly between the groups, whereas in the group of
alcoholics the mean magnitude of kloss was greater by 58%
(P = 0.0003) and the mean magnitude of Vd was reduced by 43%
(P = 0.002) (Table 1); there were no significant correlations
between the triad of FDOPA kinetic parameters and the ACQ
scores.
Within the alcoholic group, voxelwise regression of the
magnitude of Vd as a function of the ACQ scores revealed a
cluster (t .2.5) with inverse correlation in the left ventral striatum
(Figure 1F). In this cluster, the magnitudes of K did not correlate
with the ACQ scores. The magnitudes of Vd correlated inversely
with the ACQ scores, whereas the magnitudes of kloss correlated
positively with the ACQ scores, with individual smoking rates
treated as a nuisance parameter in the regressions (Table 1); there
were no significant group differences in any of the triad of FDOPA
parameters within the left ventral striatum cluster. Exclusion of
smoking rate from the GLM analysis did not substantially alter the
results, as seen in the simple plots of Figure 2 (statistical values not
shown).
Discussion
Two previous PET studies of dopamine synthesis capacity with
FDOPA in alcoholic patients yielded partially disparate results [8].
In the latter study [23], the linear graphical analysis of the net
blood-brain transfer rate of FDOPA to brain (Kin
app) revealed no
difference from an age-matched control group, but a highly
significant negative correlation between estimates of the net
transfer rate (Kin
app) in the left ventral striatum and individual ACQ
scores. In the present study, the regression analysis with the ACQ
scores of the alcoholic patients, employing the concurrent and
separate estimation of the unidirectional blood-brain clearance (K)
and the metabolite washout rate (kloss), revealed a positive
correlation with kloss and a negative correlation with Vd, but no
correlation with the magnitude of the clearance (K) in left ventral
striatum, in which no significant group differences of the three
kinetic estimates were detected. We conclude that the earlier
finding of a negative correlation between Kin
app and craving reflects
the underestimation of the unidirectional clearance of FDOPA (K)
in relation to the magnitude of washout of [18F]fluorodopamine
and its deaminated metabolites (kloss), which we determined
separately from the 120 min PET recordings in the present
analysis.
Those patients who experienced the highest craving had
relatively low estimates of Vd and high estimates of kloss in left
ventral striatum, predicting a relatively small dopamine pool,
characterized by rapid turnover. In functional anatomic terms, the
convergence within the ventral striatum of glutamatergic inputs
from limbic structures and the dopamine innervation arising in the
ventral tegmental region of the mesencephalon is thought to
subserve gating of affective signaling from limbic afferents. Given
the role of dopamine in incentive salience [34], the finding of
decreased [18F]fluorodopamine pool and its increased washout in
ventral striatum of alcoholic patients may serve to link craving
with disinhibition of dopamine turnover.
Chronic alcohol abuse is likely to alter the integrity of
dopaminergic pathways in human brain. Indeed, a number of
[11C]raclopride studies of post-synaptic D2/3 receptors revealed
reduced binding in striatum of acutely withdrawn alcoholic
patients, as compared to healthy control subjects [5,6,35237].
In contrast, other PET studies with the raclopride congeners
[18F]fallypride [38] or [18F]desmethoxyfallypride ([18F]DMFP)
[9,23], and single photon emission computed tomography
(SPECT) studies with [123I]IBZM [39] or [123I]-epidepride [40]
revealed no such changes in striatum of acutely abstinent alcoholic
patients. Disparate results likewise emerged in the studies with
FDOPA cited above, as well as other presynaptic dopamine
markers. Thus, the binding of (+)[11C]dihydrotetrabenazine to the
neuronal vesicular monoamine transporter (VMAT2) was reduced
in caudate and putamen of seven males with severe chronic
alcohol abuse [41], and an autoradiographic study revealed
reduced dopamine transporters in striatum of patients dying with
alcoholism [42], as did a SPECT study in patients [40]. In
contrast, PET studies with [11C]-methylphenidate found no such
reduction [36], or an increase in those alcoholic patients with a
history of habitual impulsivity and violence [43]. Nonetheless, a
follow-up SPECT study showed decreased dopamine transporters
in acutely detoxified patients, and a significant increase after
prolonged abstinence [44], as also seen in autoradiographic studies
of alcohol-preferring vervet monkeys [45]. Thus, there is little
consensus for the existence of a presynaptic abnormality in the
nigrostriatal pathway of alcoholic patients. On the other hand,
down-regulation of presynaptic dopamine markers in alcoholic
patients is supported by two reports of attenuated vulnerability of
Figure 1. The parametric maps show mean steady-state
storage capacity for FDOPA (Vd; ml g
21) in age-matched
control subjects (A) and in abstinent patients with alcoholism
(B), together with the subtraction map in horizontal (C) and
coronal (D) planes projected onto the MNI brain atlas. The t-
maps show clusters of voxels with t .2.8 (E: green area) for the contrast
between patients (N = 12) and age-matched healthy control subjects
(N = 16), and the cluster of voxels with t .2.5 (F: green area) for the
correlation between FDOPA-Vd and the individual score in the ACQ
questionnaire of craving in the alcoholic group, accounting for the
effect of the nuisance covariate (smoking).
doi:10.1371/journal.pone.0073903.g001
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[11C]-raclopride binding to psychostimulant challenge in alcoholic
patients [5].
The present Vd subtraction maps (Figure 1C,D) and the
voxelwise group comparison revealed significantly reduced Vd in
the left caudate head of the alcoholic group (Figure 1E), in the
absence of any change in K. This reduction in dopamine storage
capacity was driven by increased kloss, the rate of washout of
[18F]fluorodopamine together with its deaminated metabolites.
These results in alcoholic patients stand in clear distinction to our
earlier findings of increased K and decreased Vd estimates in
patients with schizophrenia, a circumstance which we termed
‘‘poverty in the midst of plenty’’ [19]. Present finding in alcoholic
patients resemble more closely the condition of Parkinson`s disease,
except for being restricted to the caudate. Indeed, the reduction of
Vd in left caudate nucleus of the present alcoholic group exceeds
that seen in patients with early Parkinson’s disease [17] and is
equivalent to that seen in three decades of healthy aging [20].
As noted in the introduction, there is no simple physiological
interpretation of decreased Vd in the caudate nucleus of abstinent
alcoholics, since it may reflect focal degeneration, increased
dopamine signaling, or conversely ‘‘futile’’ [18F]fluorodopamine
synthesis in a cellular compartment containing monoamine
oxidase. However, given the preserved estimates of K, the present
findings are more consistent with altered functional state of
dopamine innervations, rather than an actual degenerative
process. The caudate nucleus is implicated in cognitive perfor-
mance pertaining to selection of actions and evaluation of
outcomes [46], i.e., the executive functions of the frontal lobe.
In healthy control subjects, performance of ‘‘prefrontal’’ cognitive
tasks correlated with baseline and pharmacologically stimulated
FDOPA utilization in the caudate [47,48], and had a complex
age-dependence with uptake of the alternate dopamine synthesis
tracer [18F]fluoro-meta-tyrosine [49,50]. Among Parkinson’s dis-
ease patients, dopamine transporter availability in the caudate
nucleus correlated inversely with sequence learning performance
[51], whereas FDOPA utilization correlated inversely with
performance of a memory task [52], somatosensory discrimination
[53], and the Stroop interference task, as well as executive memory
and word fluency [54–56]. While the cognitive function of the
present patients was not investigated, the findings in caudate are
hypothesis-generating for a prospective FDOPA study to test the
Table 1. The upper and lower tables present mean kinetic estimates of the voxel clusters identified by parametric mapping
analysis.
Lt CDH
Controls
(n =16)
Detoxified Alcoholics
(n=12)
B (with
ACQ)
B (cigarettes
/day)
K 0.017060.0032 0.015360.0039 n.s. n.s.
kloss 0.007860.0023 0.012360.0039*** (+58%) n.s. n.s.
Vd 2.3660.77 1.3660.54** (243%) n.s. n.s.
Lt VST Controls (n=16) Detoxified Alcoholics (n=12) B (with
ACQ)
B (cigarettes
/day)
K 0.023560.0045 0.021360.0045 n.s. n.s.
kloss 0.008260.0022 0.007160.0018 0.773
{ (R: 0.725) n.s.
Vd 3.0060.88 3.3061.17 20.835
{{ (R: 0.782) n.s.
The cluster of left medial caudate head (Lt CDH) was identified in the contrast between the alcoholic and healthy groups, whereas the left ventral striatum cluster (Lt
VST) was identified by voxel-wise multivariate regression analysis with the individual ACQ scores of the patient group, partialling out the effects of cigarette
consumption (numbers of cigarettes smoked per day as a nuisance covariate). The kinetic parameters are the blood-brain FDOPA clearance corrected for loss of trapped
metabolites (K, ml g21 min21), the fractional rate constant for elimination of [18F]-fluorodopamine formed in brain (kloss, min
21), and steady-state storage of FDOPA and
its decarboxylated metabolites (Vd, ml g
21), as calculated using the linear solution of Equation 8 in [17]. Each estimate is the mean 6 SD of 16 normal controls or 12
patients. P values were calculated using GLM. Significance of difference between alcoholic and control groups: (**) P,0.005; (***) P,0.001. Standardized partial
regression coefficients (b) and multiple correlation coefficients (R) are presented for significant correlation between kinetic results in patients and ACQ scores: ({)
P,0.05; ({{) P,0.005. Results uncorrected for multiple comparisons.
doi:10.1371/journal.pone.0073903.t001
Figure 2. The scatter plots show the correlation between acute
alcohol craving and the magnitude of the fractional rate
constant for elimination of [18F]-fluorodopamine formed in
brain (upper: kloss, min
21), and steady-state storage of FDOPA
and its decarboxylated metabolites (lower: Vd, ml g
21) for the
left ventral striatum cluster. The lines indicate simple linear
regressions in these scatter plots.
doi:10.1371/journal.pone.0073903.g002
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dependence of executive function on FDOPA dynamics in caudate
of detoxified alcoholic patients.
Significant findings of the present study were asymmetric, as
noted in earlier PET studies. For example, in [11C]raclopride
studies of healthy pigs, we noted greater nicotine-evoked binding
reductions on the left side [57], and a relationship between novelty
seeking trait and amphetamine-evoked binding reductions in the
left ventral striatum [58]. In analogous human PET studies,
positive subjective effects of amphetamine correlated best with
[11C]raclopride binding changes on the left side [59], whereas
unpredicted monetary reward correlated with [11C]raclopride
binding changes on the right ventral striatum of healthy males
[60]. Although functional asymmetry has been noted in many
PET studies of the striatal dopamine innervation, there seems as
yet to be no general theory accounting for this phenomenon. In
the present context, we speculate that the left-side disturbances in
FDOPA metabolism in right-handed alcoholic patients may imply
a relationship between cognitive/affective symptoms of alcoholism
and hemispheric dominance.
There is a significant correlation between sensation-seeking
propensity and differences of extracellular dopamine and dopa-
mine receptors in the striatum [61]. The sometimes impulsive
behavior of untreated alcoholics is thought to emerge from an
underlying reward deficiency [62]. On the basis of present results,
we speculate that individual dynamics of dopamine metabolism in
ventral striatum, which would normally be expressed as trait
responsiveness to positive stimuli in healthy volunteers, has been
subverted into the expression of craving in alcoholic patients.
Whereas dopamine release in ventral striatum is implicated in the
initial vulnerability to drug seeking [63], dorsal striatum comes to
mediate compulsive drug seeking, manifesting as a maladaptive
stimulus-response habit, which is triggered and maintained by
drug-associated stimuli [64,65]. The transition from voluntary
drug use to loss of control of drug use represents a shift from
prefrontal cortical to striatal control over behaviour. This involves
a functional shift from ventral striatum, with its connectivity to the
prefrontal cortex, to progressive dominance of dorsal, motoric
divisions of the striatum [66,67], by the so-called ‘‘spiraling’’
mechanism mediated by connections through the midbrain
dopamine neurons [68,69]. The primate putamen corresponds
to the area of striatum critical for habitual control in rodents [70].
Whereas the putamen is essential for implementation of planned
actions, these actions are possibly codified by the caudate [71],
where we now present evidence for substantially increased [18F]-
fluorodopamine turnover in the alcoholic group. However, the
putative transition from a vulnerability trait mediated by greater
dopamine turnover in the ventral striatum to an acquired state of
elevated dopamine turnover in the dorsal striatum might best be
investigated in prospective molecular imaging studies of individ-
uals at risk for alcoholism.
Limitations
In general, comparisons between molecular imaging studies of
alcoholism are difficult because of factors such as age, smoking,
and other co-morbidities, cumulative alcohol intake, and duration
of abstinence. This may explain the neurochemical heterogeneity
of type I alcoholics noted in one of the previous PET studies with
FDOPA, which reported reduced Kin
app in the left caudate of two
patients [8]. Our present treatment of smoking rate as a nuisance
variable in the regression analysis is likely to have removed
possible effects of smoking on the group differences in FDOPA
kinetic parameters, and their relationship with alcohol craving
scores. Indeed, omission of smoking rate from the GLM analysis
did not significantly alter the group differences in FDOPA kinetics
or their relationship with alcohol craving scores, suggesting that
smoking history was not an important factor in the present
findings. This stands in contrast from an earlier report in which
FDOPA utilization was increased in striatum of smoking subjects
[72]. The complex effect of habitual smoking might not
completely be untangled by the ANCOVA approach, which is a
clear limitation of the present study, even though the patients are
not necessarily addicted to nicotine per se. Given the fact that the
majority of alcoholics are habitual smokers, it would also be
arguable that recruiting alcoholics that prove to have no smoking
history may not reflect the clinical reality of the drinking/smoking
comorbidity. In general, however, the comorbidity is associated
with greater severity of the illness. Considering these complexities
of clinical manifestations of alcoholism, there is no single definitive
study design. Indeed, numerous study designs could be formulat-
ed, and none of them would be fully compelling. Nonetheless, we
carefully investigated the potential bias of smoking effect, using the
ANCOVA analysis, and found negligible impact from smoking.
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